Literature DB >> 27823650

Osteoradionecrosis and intensity modulated radiation therapy: An overview.

Francesca De Felice1, Daniela Musio2, Vincenzo Tombolini3.   

Abstract

Osteoradionecrosis (ORN) is an ongoing topic, especially about its definition, pathogenesis, staging system and management algorithm. But what about its real incidence in intensity modulated radiotherapy (IMRT) era? This paper discusses the mandible in radiation therapy planning as organ at risk and reviews the literature for evidence of radiation damage, discussing likely dose constraints and the use of IMRT to reduce radiation dose to this structure. PubMed search was performed.
Copyright © 2016. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Dose; Head and neck cancer; IMRT; Mandible; Osteoradionecrosis; Toxicity

Mesh：

Year:  2016        PMID： 27823650     DOI： 10.1016/j.critrevonc.2016.08.017

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN： 1040-8428            Impact factor:   6.312


  10 in total

1.  Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma.

Authors:  Francesca De Felice; Luigia Vetrone; Nadia Bulzonetti; Rossella Caiazzo; Francesco Marampon; Daniela Musio; Vincenzo Tombolini
Journal:  Med Oncol       Date:  2019-06-12       Impact factor: 3.064

2.  Eagle Syndrome Secondary to Osteoradionecrosis of the Styloid Process.

Authors:  Anna K Bareiss; David Z Cai; Amit S Patel; Brian A Moore
Journal:  Ochsner J       Date:  2017

Review 3.  Treatment of late sequelae after radiotherapy for head and neck cancer.

Authors:  Primož Strojan; Katherine A Hutcheson; Avraham Eisbruch; Jonathan J Beitler; Johannes A Langendijk; Anne W M Lee; June Corry; William M Mendenhall; Robert Smee; Alessandra Rinaldo; Alfio Ferlito
Journal:  Cancer Treat Rev       Date:  2017-07-18       Impact factor: 12.111

Review 4.  Osteoradionecrosis of the Maxilla: Conservative Management and Reconstructive Considerations.

Authors:  Tom Shokri; Weitao Wang; Aurora Vincent; Jason E Cohn; Sameep Kadakia; Yadranko Ducic
Journal:  Semin Plast Surg       Date:  2020-05-06       Impact factor: 2.314

Review 5.  Radiotherapy Controversies and Prospective in Head and Neck Cancer: A Literature-Based Critical Review.

Authors:  Francesca De Felice; Antonella Polimeni; Valentino Valentini; Orlando Brugnoletti; Andrea Cassoni; Antonio Greco; Marco de Vincentiis; Vincenzo Tombolini
Journal:  Neoplasia       Date:  2018-02-12       Impact factor: 5.715

6.  Cell therapy stimulates bone neoformation in calvaria defects in rats subjected to local irradiation.

Authors:  Ana Luisa Riul Sório; Paula Katherine Vargas-Sanchez; Roger Rodrigo Fernandes; Dimitrius Leonardo Pitol; Luiz Gustavo de Sousa; Adriano Luiz Balthazar Bianchini; Geraldo Batista de Melo; Selma Siessere; Karina Fittipaldi Bombonato-Prado
Journal:  Animal Model Exp Med       Date:  2019-07-01

Review 7.  Nanotechnology in Oral Cavity Carcinoma: Recent Trends and Treatment Opportunities.

Authors:  Francesca De Felice; Costanza Cavallini; Alberta Barlattani; Mario Tombolini; Orlando Brugnoletti; Vincenzo Tombolini; Antonella Polimeni
Journal:  Nanomaterials (Basel)       Date:  2019-10-31       Impact factor: 5.076

Review 8.  Immune Check-Point Inhibitors and Standard Chemoradiotherapy in Definitive Head and Neck Cancer Treatment.

Authors:  Francesca De Felice; Daniela Musio; Vincenzo Tombolini
Journal:  J Pers Med       Date:  2021-05-10

9.  A Novel Treatment Concept for Advanced Stage Mandibular Osteoradionecrosis Combining Isodose Curve Visualization and Nerve Preservation: A Prospective Pilot Study.

Authors:  Gustaaf J C van Baar; Lars Leeuwrik; Johannes N Lodders; Niels P T J Liberton; K Hakki Karagozoglu; Tymour Forouzanfar; Frank K J Leusink
Journal:  Front Oncol       Date:  2021-02-22       Impact factor: 6.244

10.  Is the Risk to Develop Osteoradionecrosis of the Jaws Following IMRT for Head and Neck Cancer Related to Co-Factors?

Authors:  Eli Rosenfeld; Bassel Eid; Daya Masri; Aron Popovtzer; Aviram Mizrachi; Gavriel Chaushu
Journal:  Medicina (Kaunas)       Date:  2021-05-11       Impact factor: 2.430
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.